Taoqian Zhao

Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)

Zhonghua Li, Lina Ding, Zhongrui Li et al. · Acta Pharmaceutica Sinica B · 2019 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of [1,2,3]Triazolo[4,5-<i>d</i>]pyrimidine Derivatives as Novel LSD1 Inhibitors

Zhonghua Li, Xue‐qi Liu, Feng‐Zhi Suo et al. · ACS Medicinal Chemistry Letters · 2017 · 73 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors

Zhenzhen Liu, Taoqian Zhao, Zhonghua Li et al. · Acta Pharmaceutica Sinica B · 2019 · 48 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Design, synthesis and in vitro biological evaluation of novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives containing a thiosemicarbazide moiety

Xue‐Qi Liu, Taoqian Zhao, Congcong Wang et al. · European Journal of Medicinal Chemistry · 2018 · 38 citations

Pharmacy, Medicinal Chemistry, Pharmacology +12

Identification of thiazolo[5,4-d]pyrimidine derivatives as potent antiproliferative agents through the drug repurposing strategy

Zhonghua Li, Ji Zhang, Xue‐Qi Liu et al. · European Journal of Medicinal Chemistry · 2017 · 33 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13